Our Research Strategy
We have a bold ambition: to stop prostate cancer from being a killer. And it’s through funding research that we will make this happen.
This goal is underpinned by our ambitious research strategy: ten years to tame prostate cancer. It sets out how we invest in the most innovative ideas to accelerate improvements for men. Specifically, we focus on funding research in three key areas: better diagnosis, better treatments and better prevention. By tackling these areas, we can make the biggest impact to men with, or at risk of, prostate cancer.
We need to improve diagnosis of prostate cancer to make sure we always catch the disease in the early stages, while it can still be cured. We’re funding research into better diagnostic tests, that can reliably spot aggressive cancer that needs treating from those that can be safely watched. One day, we aim for this research to help lay the groundwork to giving men a screening programme for prostate cancer, so more cancers are caught before it’s too late.
Men deserve better treatments for prostate cancer. The treatments we have for advanced prostate cancer work well for some men, but others aren’t so lucky. We’ve committed over £2 million to our precision medicine programme – to give men treatments that will target the specific ‘Achilles’ heel’ of their cancer, instead of the ‘one-size-fits-all’ approach we have today. We also need treatments for localised prostate cancer that doesn’t leave them with life-long side effects. We fund research into new technology to treat localised disease so that men don’t have to choose curing their cancer over their quality of life.
We need to learn more about how prostate cancer grows and develops, so that we can prevent this from happening in the first place. We fund research to learn about the basic biology of prostate cancer, and support cutting-edge projects to help men’s immune systems provide them with long-term protection from the disease.Read our Research Strategy